Navigation Links
Gambling monkeys give insight into neural machinery of risk

might be more risk prone and impulsive," said Platt. "Disturbances in such neurotransmitter systems might be the basis of pathological conditions like pathological gambling, obsessive-compulsive disorder and depression. We can do pharmacological manipulation of the serotonin system in monkeys to see how it influences risk perception and risk preferences, and whether we see changes at the level of the single neurons that we're studying."

What's more, said Platt, the studies with monkeys can guide studies in mice, in which scientists can make genetic alterations in the mice and study the behavioral effects of those alterations. Such studies could contribute to understanding of the genetic basis of compulsive behaviors and other such behavioral disorders.


'"/>

Source:Duke University Medical Center


Page: 1 2 3 4

Related biology news :

1. Rhesus monkeys can assess the visual perspective of others when competing for food
2. Logging changed ecological balance for monkeys, damaged health
3. Performing monkeys in Asia carry viruses that could jump species to humans
4. Genetic and environmental influences on alcohol consumption among rhesus monkeys
5. Executive monkeys influenced by other executives, not subordinates
6. Rhesus monkeys in Nepal may provide new alternative for HIV/AIDS research
7. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
8. Implanting dopamine generators in brain cells obtains improvement in Parkinsons in monkeys
9. New insight into people who see colors in letters and numbers
10. Alaskan puzzles, monitoring provide insight about North Pacific salmon runs
11. New insight into regulation of blood stem cells
Post Your Comments:
(Date:12/4/2009)... activity in organs relevant for coronary artery disease (CAD), ... identified a module of genes that is important for ... plaque. The findings, which are to be published in ... targeting the migration of white blood cells in the ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
(Date:12/3/2009)... new information and adapt to changes in our daily environment, ... in the minute junctions where nerve cells communicate, according to ... study is published online this week in the journal ... PhD, associate professor of physiology and neuroscience at NYU School ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 1Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 2The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 1The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 2The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 3The Alpha 1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics Inc 14451 4FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 1FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 2FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets 5446 3
... The way aquatic plants respond to plant disease ... land-based agriculture, say plant pathologists with The American ... III, Cornell University, Ithaca, NY, many aquatic plants ... "Through further study, plant pathologists may be able ...
... virus infiltrates human cells to cause encephalitis. Designated as ... Agenda, the virus exploits a protein essential to embryonic ... online edition of Nature reports the findings July 6. ... be used as a potential bioterrorism agent capable of ...
... blood disease, primarily affecting males, where the blood ... one in 6000 Australian males is born with ... with haemophilia rely on intravenous infusion of recombinant ... and her Harvard colleagues have made ground-breaking discoveries ...
Other Biology News:UCLA scientists reveal how Nipah virus infects cells 2Promising therapies for haemophilia & heart disease 2
(Date:12/2/2009)... Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) ... endocrine therapy and oncology, today announced that the ... Fast Track designation for the Company,s PI3K/Akt pathway ... relapsed/refractory multiple myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( ...
(Date:12/2/2009)... leading scientific magazine covering the life sciences, ranked Photometrics’ Evolve ... of 2009. , ... (PRWEB) December ... Photometrics ®, a designer and manufacturer of high-performance ...
(Date:12/1/2009)... that he has joined Carolina Eyecare Physicians and ... , which was developed by Medical Consulting Group. ... implant, and cataract surgery expert who has been ... vision correction surgery. He is a member ...
(Date:12/1/2009)... Dec. 1 Reportlinker.com announces that a new ... ,, Chromium - Global Market Trends ... demand for chromium is primarily influenced by stainless ... turbine markets is also important for growth of ...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
... NV (Euronext,Brussels: THR), a biotechnology company focused on ... financial results for the seven month,period ending 30 ... funds to invest in its development pipeline and ... programs. Highlights - Successful placing of ...
... Aug. 24 AGA Medical Corporation ("AGA"),announced today ... Administration,(FDA) and European CE Mark approvals for the ... AMPLATZER Vascular Plug II expands the AGA family ... vessel and blood vessel,malformations in the peripheral vasculature. ...
... announced today the,release of two major upgrades to ... multilaser capability and the Beta release of a ... well beyond,conventional optical limitations. The Multilaser upgrade ... additional lasers including a 405nm (violet) laser and ...
Other Biology Technology:ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 2ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 3ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 4ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 5ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 6ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 7ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 8ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 9ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 10ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 11AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II 2Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2
DNA sequencing - plasmids or PCR fragments, 3-7 working days service....
Polyclonal Antibody to Golgin-67...
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Biology Products: